| Application no. and date | 18825837.0 (espacenet) (Federated) (European Patent Register), 20181129 | | Patent/reg. no. and date | DK/EP 3716992, 20220810 | | Publication date | 20201007 | | Priority no. and date | US 201762593033 P, 20171130, US 201862644425 P, 20180317, US 201862748782 P, 20181022 | | EP pub. no. and date |
EP 3716992 20201007 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | V447989DK00 | | Inventor | VITTI, Robert L., c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown
New York 10591, US,
BERLINER, Alyson J., c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown
New York 10591, US,
CHU, Karen, c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown
New York 10591, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61P 27/02 (2006.01) | | Title | Anvendelse af en VEGF-antagonist til behandling af angiogene øjenlidelser | | Int. application no. | US2018063025 | | Int. publication no. | WO2019108770 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
